[
    [
        {
            "time": "2021",
            "original_text": "2021年中国医药流通行业区域竞争格局分析 广东在多个市场处于领先【组图】",
            "features": {
                "keywords": [
                    "医药流通",
                    "区域竞争",
                    "广东",
                    "领先"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "2021年中国医药流通行业区域竞争格局分析 广东在多个市场处于领先【组图】",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业周报：医疗服务三问三答 何时会出现板块性机会？",
            "features": {
                "keywords": [
                    "医药生物",
                    "医疗服务",
                    "板块性机会"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业周报：医疗服务三问三答 何时会出现板块性机会？",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-08-09 - 2021-08-13",
            "original_text": "【兴业医药】坚守大赛道龙头，寻找“专精特新”小龙头 - 医药行业周报（2021.08.09.-2021.08.13）",
            "features": {
                "keywords": [
                    "专精特新",
                    "小龙头",
                    "医药行业"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【兴业医药】坚守大赛道龙头，寻找“专精特新”小龙头 - 医药行业周报（2021.08.09.-2021.08.13）",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业：关注CXO新秀 重点推荐皓元医药、诺泰生物等",
            "features": {
                "keywords": [
                    "医药生物",
                    "CXO",
                    "皓元医药",
                    "诺泰生物"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业：关注CXO新秀 重点推荐皓元医药、诺泰生物等",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021",
            "original_text": "【国元医药|点评】长春高新2021年中报点评：生长激素维持高速增长，疫苗板块未来可期",
            "features": {
                "keywords": [
                    "长春高新",
                    "生长激素",
                    "疫苗板块",
                    "高速增长"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【国元医药|点评】长春高新2021年中报点评：生长激素维持高速增长，疫苗板块未来可期",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]